Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.
With efforts to tackle fake drugs in Africa increasing, the WHO's director-general speaks on the need to shorten the supply chain with local manufacturing.
update - WHO outlines biosimilarity requirements and inspection plan
The WHO has announced plans to extend its prequalification scheme to include cancer biosimilars and says it will pressure industry for fairer prices for all biologics.
The joint US FDA and EMA active pharmaceutical ingredient (API) manufacturing facility inspection programme has signed up the World Health Organisation as a member.
The WHO has stopped sending free drugs to private hospitals and non-governmental organisations in Haiti after receiving reports that some institutions in the earthquake stricken country had begun to charge patients.
The WHO has issued Sandoz with a Notice of Concern (NoC) after an inspection of the firm’s Kempton Park facility in South Africa identified 41 deviations from GMP standards.
The drug control authorities in Vietnam are being aided in the
fight against counterfeit drugs by a mobile laboratory system
developed by the German Pharma Health Fund (GPHF).